Dobivanje i korištenje transgeničnih životinja

Dobivanje i korištenje
transgeničnih životinja
Doc.dr.sc. Dinko Mitrečić, dr.med.
Voditelj Laboratorija za matične stanice
Hrvatski institut za istra
živanje mozga
Medicinski fakultet Sveučilišta u Zagrebu
Geni - genske preinake…
 Značenje genskog
zapisa (genoma)?
 Uloga gena?
 Kolika mi je sklonost
da ću oboljeti od…?
 Koliko ću dugo
živjeti?
 Tržište znanja!
Kako otkriti ulogu gena?
Klasična genetika
FENOTIP
ULOGA GENA ?
PROMJENE
FENOTIPA
KOJI JE GEN
ZAHVAĆEN?
Laboratorijske životinje kao predmet
proučavanja
Zašto miševi?
 Male životinje, velika legla, kratko
generacijsko razdoblje, dobro podnose život
u zatočeništvu, troškovi niski
 Visoko srođene linije
 Niz generacija sparivanje životinja iz istog legla
 Sve životinje genetski iste (poput blizanaca)
 Dokaz: nema odbacivanja presatka
tc/tc E12,5
Fotografije preuzete iz Colour Atlas of Congenital Malformation Syndromes
Kako otkriti ulogu gena?
Obrnuta genetika
GEN
MUTACIJA
FENOTIP
Kako odrediti ulogu gena?
ili
Koja genetska preinaka?
 Onemogućavanje uloge gena (loss of
function, knock-out)
 Nadodavanje uloge gena (gain of function,
transgenični miš)
Transgenični miš:
miš s dodatnom kopijom gena u
genomu
ili
bilo koji genetski preinačeni miš
The mouse gene Noto is expressed in the tail bud and essential for its morphogenesis
Marica Zizic Mitrecic, Dinko Mitrecic, Roland Pochet,
Ljiljana Kostovic-Knezevic, Srecko Gajovic
Laboratory for Neurogenetics and Genetics of Development, Croatian Institute for Brain Research, School of Medicine, University of
Zagreb, Zagreb, Croatia
Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Center Zagreb, Zagreb, Croatia
Laboratoire d'histologie générale, de neuroanatomie et de neuropathologie, Faculté de Médecine, Université Libre de Bruxelles,
Bruxelles, Belgium
Kako načiniti transgeničnog
miša?
 Injiciranjem oocite (engl. Oocyte injection)
 Injicira se DNA koja sadrži dodatnu kopiju
gena
 Takva DNA se konstruira postupcima
bakterijske genetike (pomoću plazmida)
Analyse the progeny
by PCR or Southern blotting
Transgene DNA
Production of transgenic mice
by pronuclear microinjection
Pronuclear injection of DNA into fertilized ova
Injection pipette
containing DNA
Holding pipette
Fertilised ova
(> 1 day old)
Introduction of correctly modified stem cells in “host” blastocysts
Injected blastocyst
Host blastocyst
Injection pipette
Holding pipette
Host’s stem cell mass
injected stem cells
Pokaži film!
Eppendorf
mikroinjektor
P: Kako knock-out-irati gen?
O: Homolognom
rekombinacijom
Ciljana promjena gena postiže se
homolognom rekombinacijom
Ciljana promjena gena postiže se
homolognom rekombinacijom
Ciljana promjena gena postiže se
homolognom rekombinacijom
Embrionalne matične stanice
(engl. embryonic stem (ES) cells)
Od kuda se dobivaju embrionalne
matične stanice?
 Zametak na
stadiju blastociste
Embrionalne matične stanice
(engl. embryonic stem (ES) cells)
Early mouse development
From
Sedivy &
Joyner
“Gene
Targeting”
1992
Razvoj mišjeg zametka
Izolacija mišje maternice
Ispiranje (flushing) mišje maternice – dobivanje blastocista
Embryonic Stem Cell Isolation
remove zona pellucida
from blastocyst
Microsurgery
Immunosurgery
Blastocyst
Outgrowth
antibody
binding
cut TE
dissect
off ICM
trypsinize
pipet off
ICM
complement
TE cells
lyse
trypsinize
plate on feeder
cell layer
Embrionalne matične stanice
(engl. embryonic stem (ES) cells)
Dokazi totipotentnosti
embrionalnih matičnih stanica
• In vitro (u kulturi stanica)
• In vivo (vratiti ih natrag u razvitak
zametka)
Embryoid bodies
Undifferentiated ES cells
4 days
up to 9 days
Culture in suspension + retinoic acid
Plating on substrate
Neuron-like cells after differentiation of ES cells
(10-6 M retinoic acid, after 5 days of culture)
10-7 M retinoic acid
after 2 days of culture
Anti NF-M - fluorescein
10-7 M retinoic acid
after 9 days
Anti GFAP - rhodamine
Pax6 expression (10-6 M retinoic acid, after 2 days of culture)
Kamo se mogu ugraditi
embrionalne matične stanice?
 opet u blastocistu
Superovulation
-3 – 5 wk old females (prepubescent age)
- treatment with 5 i.u. of PMSG (pregnant mare’s serum
gonadotropin) intraperitoneally, mimicking folliclestimulating hormone on day –2 (i.e. Saturday at 14 h)
- treatment with 5 i.u. of hCG (human chorionic
gonadotropin) 46 – 48 h upon PMSG treatment (i.e.
Monday at 12 h)
- mating set up withihn 6 h after the hCG treatment
Od gentski preinačenih embrionalnih matičnih
stanica do genetski preinačenog miša
ES cell
Chimera Production
Blastocyst
Injection
Aggregation
Flush embryos
Uterus
E3.5
Oviduct
E2.5
Morula
Blastocyst
ES cells
Remove zona pellucida
Darning needle
aggregation
Recover 1-2 hours
culture overnight
implant into pseudopregnant
surrogate mother
Mating set up for transfer of 3.5 day embryo
Donors of embryo
Acceptors of embryo
(pseudo-pregnant females,
foster mothers)
Fertile female
X
Fertile male
Fertile female
X
Vasectomised (sterile) male
Breeding start: Monday,
Plug check: Tuesday
Breeding start: Tuesday,
Plug check: Wednesday
Coat color difference!
Coat Color Chimeras
Chimeric Progeny
Chimera
ES cell injection into blastocyst
C57BL/6
Blastocyst
(black)
agouti black
ES cells
129/SvJ
(agouti)
Prijenos zametaka u lažno trudnu ženku
-/wt
-/wt
wt/wt wt/wt
wt/wt
S.M.
PCR
-/wt
wt/wt
wt/wt
no DNA
no result
320bp
180bp
Kako prepoznati u kojem klonu
embrionalnih matičnih stanica je
došlo do homologne
rekombinacije?
Embrionalne matične stanice koje su doživjele
homolognu rekombinaciju prepoznate su
hibridizacijom po Southernu
Kako ću dokazati da sam zaista
onemogućio gen koji proučavam?
Koja je posljedica
onemogućavanja gena?
Kakav je fenotip homozigota?
Koja je uloga proučavanog gena?
The use of genetically modified
mouse





Gene function
Mouse models for human disease
Novel diagnostic procedures
Novel therapeutic approaches
Drug testing on mouse mutants
Charcot, J., Joffroy, A: Deux cas d’atrophie musculaire progressive avec lesions de la
substance grise et des faisceaux antero-lateraux de la moelle epiniere. Arch. Physiol.
Neurol. Pathol. 2, 744–754. 1869.
I am so tired and I simply can not play well anymore...
…the bad news is this “lateral sclerosis”…they told me it is probably caused by some germ...
Prevalence: 4 to 6 in 100,000 (motor neuron disease No.1)
- 90% sporadic (SALS)
(wide range of mutations without clear common factor)
- 10% familial (FALS)
SOD1 (superoxide dismutase 1)
VAPB (vesicle associated membrane protein)
SETX (senatexin)
DCTN1 (dynectin)
ALSIN (ALS2)
TDP-43
SOD1 (Cu/Zn-SOD1)
Rosen DR et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial
amyotrophic lateral sclerosis. Nature. 1993 Mar 4;362(6415):59-62
The SOD-catalysed dismutation of superoxide :
M(n+1)+ − SOD + O2− → Mn+ − SOD + O2
Mn+ − SOD + O2− + 2H+ → M(n+1)+ − SOD + H2O2.
153 amino acids with 134 reported distinct amino acid changes.
All of these mutations result in essentially the same disease, more or less
rapidly progressive ALS.
Almost any alteration in the structure of SOD1 gene will cause ALS and no
other pathology.
Some SOD1 mutations change tertiary conformation drastically,
some not at all.
Some change binding of Cu, some Zn, some both, some do not change
anything.
KO SOD1 mutants and overexpressing mutants showed that ALS pathology is
independent of any kind of enzyme activity.
Spontaneous SOD1 mouse mutant were reported as phenotypically normal (Luche et al., 1997).
Basic prerequisite: multicopy presence of SOD1 (human, murine, mutated anyhow…)
Problem of life lenghth?
Genetics
activity
protein conformation
…
protein
And what about mutSOD1 interactions ?
- mutSOD1 proteins are more susceptible to form detergent-insoluble SOD1
oligomers that progressively aggregate and form inclusion bodies, which are the
hallmark of ALS pathology.
- generally, mutSOD1 is more sensitive to low levels of oxidative stress than
wtSOD1
mitochondrial dysfunction
protein
aggregation
oxidative
chemistry
synapse disactivity
bad neigborhood
structural and transport defects of axons
1. Cell replacement therapy
Dobivanje i korištenje
transgeničnih životinja
Doc.dr.sc. Dinko Mitrečić, dr.med.
Voditelj Laboratorija za matične stanice
Hrvatski institut za istra
živanje mozga
Medicinski fakultet Sveučilišta u Zagrebu